PDCD1 and non-small cell lung carcinoma: One study compared several predictive parameters for the use of PD-1/PD-L1 inhibitors in non-small cell lung cancer (NSCLC) and believed that the expression of PD-1/PD-L1 was the most valuable predictor (27).